Network-based prediction for sources of transcriptional dysregulation using latent pathway identification analysis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 32, 2011, Pages 13347-13352

  Pham, Lisa ^a   Christadore, Lisa ^b   Schaus, Scott ^b   Kolaczyk, Eric D ^b  

^a BOSTON UNIVERSITY   (United States)

^b Boston University   (United States)

Author keywords

Centrality; Microarray; Pathway network

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GELDANAMYCIN; HEAT SHOCK PROTEIN 90; MITOGEN ACTIVATED PROTEIN KINASE 1; T CELL FACTOR PROTEIN; TRANSFORMING GROWTH FACTOR BETA; WNT1 PROTEIN;

ANGIOGENESIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CARCINOMA CELL; CELL ADHESION; CELL PROLIFERATION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ENZYME ACTIVITY; GENE EXPRESSION PROFILING; GENE SET ENRICHMENT ANALYSIS; GENETIC ANALYSIS; GENETIC IDENTIFICATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LATENT PATHWAY IDENTIFICATION ANALYSIS; LUNG CARCINOMA; MALE; METASTASIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE PHOSPHORYLATION; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE CARCINOMA; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TREATMENT RESPONSE;

BENZOQUINONES; BIOLOGICAL PROCESSES; COMPUTATIONAL BIOLOGY; DIABETES MELLITUS, TYPE 2; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HSP90 HEAT-SHOCK PROTEINS; HUMANS; LACTAMS, MACROCYCLIC; MALE; NEOPLASM METASTASIS; PROSTATIC NEOPLASMS; TRANSCRIPTION, GENETIC;

EID: 80051978793     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1100891108     Document Type: Article

References (41)

1. Subramanian A., et al. (2005) Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102:15545-15550. (Pubitemid 41528093)
2. Ideker T., Ozier O., Schwikowski B., Siegel A.F. (2002) Discovering regulatory and signalling circuits in molecular interaction networks. Bioinformatics 18(Suppl 1):S233-S240. (Pubitemid 41185658)
3. Liu M., et al. (2007) Network-based analysis of affected biological processes in type 2 diabetes models. PLoS Genet 3:e96.
4. Huttenhower C., et al. (2009) Exploring the human genome with functional maps. Genome Res 19:1093-1106.
5. Nariai N., Kolaczyk E.D., Kasif S. (2007) Probabilistic protein function prediction from heterogeneous genome-wide data. PLoS ONE 2:e337.
6. Lucas J., et al. (2006) Sparse statistical modelling in gene expression genomics. Bayesian Inference for Gene Expression and Proteomics, eds Do KA, Muller P, Vannucci M (Cambridge Univ Press, Cambridge, UK), pp 155-176.
7. Vogelstein B., Kinzler K.W. (2004) Cancer genes and the pathways they control. Nat Med 10:789-799. (Pubitemid 39070849)
8. Kanehisa M., et al. (2006) From genomics to chemical genomics: New developments in KEGG. Nucleic Acids Res 34(Database issue):D354-D357.
9. Kanehisa M., Goto S. (2000) KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28:27-30. (Pubitemid 30047706)
10. Ashburner M. (2000) Gene Ontology: Tool for the unification of biology. The Gene Ontology Consortium Nat Genet 25:25-29.
11. Bacac M., Stamenkovic I. (2008) Metastatic cancer cell. Annu Rev Pathol 3:221-247. (Pubitemid 351488281)
12. Yardy G.W., Brewster S.F. (2005) Wnt signalling and prostate cancer. Prostate Cancer Prostatic Dis 8:119-126. (Pubitemid 43118074)
13. El Sheikh S.S., Domin J., Abel P., Stamp G., Lalani N. (2003) Androgen-independent prostate cancer: Potential role of androgen and ErbB receptor signal transduction crosstalk. Neoplasia 5:99-109. (Pubitemid 36369005)
14. Shah R.B., Ghosh D., Elder J.T. (2006) Epidermal growth factor receptor (ErbB1) expression in prostate cancer progression: Correlation with androgen independence. Prostate 66:1437-1444. (Pubitemid 44350369)
15. Feldman B.J., Feldman D. (2001) The development of androgen-independent prostate cancer. Nat Rev Cancer 1:34-45. (Pubitemid 33741879)
16. Gioeli D., Mandell J.W., Petroni G.R., Frierson H.F., Jr., Weber M.J. (1999) Activation of mitogen-activated protein kinase associated with prostate cancer progression. Cancer Res 59:279-284. (Pubitemid 29048852)
17. Bierie B., Moses H.L. (2006) Tumour microenvironment: TGFbeta: TGFbetaThe molecular Jekyll and Hyde of cancer. Nat Rev Cancer 6:506-520. (Pubitemid 43980540)
18. Tu W.H., et al. (2003) The loss of TGF-beta signaling promotes prostate cancer metastasis. Neoplasia 5:267-277. (Pubitemid 36754056)
19. Saha B., et al. (2008) Overexpression of E-cadherin and beta-catenin proteins in metastatic prostate cancer cells in bone. Prostate 68:78-84.
20. Jaggi M., et al. (2005) Aberrant expression of E-cadherin and beta-catenin in human prostate cancer. Urol Oncol 23:402-406. (Pubitemid 41654506)
21. Martin T.A., Jiang W.G. (2009) Loss of tight junction barrier function and its role in cancer metastasis. Biochim Biophys Acta 1788:872-891.
22. Sakamoto S., McCann R.O., Dhir R., Kyprianou N. (2010) Talin1 promotes tumor invasion and metastasis via focal adhesion signaling and anoikis resistance. Cancer Res 70:1885-1895.
23. Cooper C.R., Pienta K.J. (2000) Cell adhesion and chemotaxis in prostate cancer metastasis to bone: A minireview. Prostate Cancer Prostatic Dis 3:6-12. (Pubitemid 30616513)
24. Zhou Z., et al. (2006) Synergy of p53 and Rb deficiency in a conditional mouse model for metastatic prostate cancer. Cancer Res 66:7889-7898. (Pubitemid 44299151)
25. Ni Z., Lou W., Leman E.S., Gao A.C. (2000) Inhibition of constitutively activated Stat3 signaling pathway suppresses growth of prostate cancer cells. Cancer Res 60:1225-1228. (Pubitemid 30151988)
26. Neckers L., Schulte T.W., Mimnaugh E. (1999) Geldanamycin as a potential anti-cancer agent: Its molecular target and biochemical activity. Invest New Drugs 17:361-373. (Pubitemid 30135903)
27. Grenert J.P., et al. (1997) The amino-terminal domain of heat shock protein 90 (hsp90) that binds geldanamycin is an ATP/ADP switch domain that regulates hsp90 conformation. J Biol Chem 272:23843-23850. (Pubitemid 27410964)
28. Whitesell L., Lindquist S.L. (2005) HSP90 and the chaperoning of cancer. Nat Rev Cancer 5:761-772. (Pubitemid 41400776)
29. McIlwrath A.J., Brunton V.G., Brown R. (1996) Cell-cycle arrest and p53 accumulation induced by geldanamycin in human ovarian tumour cells. Cancer Chemother Pharmacol 37:423-428. (Pubitemid 26054550)
30. Kim H.R., Lee C.H., Choi Y.H., Kang H.S., Kim H.D. (1999) Geldanamycin induces cell cycle arrest in K562 erythroleukemic cells. IUBMB Life 48:425-428.
31. Plate J.M., Iyengar R.M., Sutton P., Bonomi P. (2007) Nrdp1 and ErbB3 expression in nonsmall cell lung cancer lines.: C7-05. Proffered Paper Abstracts: C7-05. Proffered Paper AbstractsSession C7: C7-05. Proffered Paper AbstractsSession C7Tumor and Cell Biology C7-05. J Thorac Oncol 2:S381.
32. Keshava Prasad T.S., et al. (2009) Human protein reference database - 2009 update. Nucleic Acids Res 37(Database issue):D767-D772.
33. Gallagher I.J., et al. (2010) Integration of microRNA changes in vivo identifies novel molecular features of muscle insulin resistance in type 2 diabetes. Genome Med 2:9.
34. Mootha V.K., et al. (2003) PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34:267-273. (Pubitemid 36792858)
35. Misu H., et al. (2007) Genes involved in oxidative phosphorylation are coordinately upregulated with fasting hyperglycaemia in livers of patients with type 2 diabetes. Diabetologia 50:268-277.
36. Vondra K., et al. (1977) Enzyme activities in quadriceps femoris muscle of obese diabetic male patients. Diabetologia 13:527-529. (Pubitemid 8206741)
37. Petersen K.F., Dufour S., Befroy D., Garcia R., Shulman G.I. (2004) Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350:664-671. (Pubitemid 38364625)
38. Takamura T., et al. (2008) Obesity upregulates genes involved in oxidative phosphorylation in livers of diabetic patients. Obesity 16:2601-2609.
39. Feng Y., Mitchison T.J., Bender A., Young D.W., Tallarico J.A. (2009) Multi-parameter phenotypic profiling: Using cellular effects to characterize small-molecule compounds. Nat Rev Drug Discov 8:567-578.
40. Terstappen G.C., Schlüpen C., Raggiaschi R., Gaviraghi G. (2007) Target deconvolution strategies in drug discovery. Nat Rev Drug Discov 6:891-903. (Pubitemid 350042397)
41. Varambally S., et al. (2005) Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. Cancer Cell 8:393-406. (Pubitemid 41579834)